Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Self-amplifying RNA could be a better option for protein replacement therapy with lower doses and lasting effects, but delivering it into cells is still challenging.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

PCOS is linked to diabetes and insulin resistance, and managing AGEs may help treat related symptoms.

Young women with PCOS without additional risk factors may have normal heart function.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Obesity leads to physical, metabolic, reproductive issues, higher healthcare costs, and mental health problems.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hair loss in young men in Central India is linked to severe heart disease.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cyproterone acetate with ethinyl estradiol is effective for treating skin symptoms related to high androgen levels, like in PCOS.

SHBG may be a useful early indicator and treatment target for PCOS.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

High testosterone increases heart disease risk in women with PCOS.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Certain gene variants in estrogen receptors are linked to polycystic ovary syndrome, mainly affecting metabolism, in Tunisian women.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Melatonin may help treat PCOS symptoms in rats.

The article concludes that global standardization in PCOS research is crucial for accurate diagnosis and understanding of the condition.